If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder UK Mid & Small Cap Fund Regulatory News (SCP)

Share Price Information for Schroder UK Mid & Small Cap Fund (SCP)

Share Price is delayed by 15 minutes
Get Live Data
710.00    -16.00 (-2.20%)
Bid:
710.00
Ask:
724.00
Spread: 14.00 (1.972%)
Market Cap: £234.38m
SCP Live PriceLast checked at - London Stock Exchange

Intraday Schroder UK Mid & Small Cap Fund Share Chart

Tender Pool Update

Today 07:00

RNS Number : 0471L
Schroder UK Mid Cap Fund PLC
06 July 2026
 

6 July 2026

 

SCHRODER UK MID CAP FUND PLC

(the "Company")

 

Tender Pool Update

 

 

The Company announced the results of its Tender Offer on 24 June 2026, pursuant to which 11,445,798 of the Company's Shares will be repurchased. 

 

The Tender Pool of assets in respect of these Tendered Shares has been established in accordance with the terms of the Tender Offer and is in the process of being realised. 

 

As at close of business on 2 July 2026, the composition of the Tender Pool was as follows:

 

Equities (£)

48,930,833.02

Cash (£)

38,035,480.30

Total Value (£)

86,966,313.32

 

Tendered Shares held in escrow 11,445,798

 

Tender Pool NAV per Share 759.8100p 

 

Capitalised terms shall have the meaning given to them in the Company's circular to shareholders in respect of the tender offer published on 20 May 2026.

 

Notice for US Shareholders

 

The tender offer relates to securities of a non-U.S. company organized in England and Wales and listed on the London Stock Exchange and is subject to the disclosure requirements, rules and practices applicable to companies listed in the United Kingdom, which differ from those of the United States in certain material respects. A circular will be prepared in accordance with U.K. style and practice for the purpose of complying with the laws of England and Wales and the rules of the FCA and of the London Stock Exchange. The tender offer is not subject to the disclosure or other procedural requirements of Regulation 14D under the U.S. Securities Exchange Act of 1934, as amended. The tender offer will be made in the United States pursuant to Section 14(e) of, and Regulation 14E under, the Exchange Act, subject to the exemptions provided by Rule 14d-1(d) thereunder, and otherwise in accordance with the requirements of the rules of the FCA and the London Stock Exchange. Accordingly, the tender offer will be subject to disclosure and other procedural requirements that are different from those applicable under U.S. domestic tender offer procedures and law. The Company is not listed on an American securities exchange, is not subject to the periodic reporting requirements of the Exchange Act and is not required to, and does not, file any reports thereunder.

 

It may be difficult for U.S. shareholders to enforce certain rights and claims arising in connection with the tender offer under U.S. federal securities laws, because the Company is located outside the United States, and its officers and directors reside outside the United States. It may not be possible to sue a non-U.S. company or its officers or directors in a non-U.S. court for violations of U.S. securities laws. It also might not be possible to compel a non-U.S. company or its affiliates to subject themselves to a U.S. court's judgment.

 

To the extent permitted by applicable law and in accordance with normal U.K. practice, the Company or Investec or any of their affiliates may make certain purchases of, or arrangements to purchase, shares of the Company outside the United States during the period in which the tender offer remains open for acceptance, including sales and purchases of shares effected by Investec acting as market maker in the Shares.

 

 

 

Enquiries:

 

Schroder Investment Management Limited

Phoebe Merrell (Company Secretary)

Tel: 020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSSSFMDEMSEEW
Date   Source Headline
29th Nov 202410:58 amRNSNet Asset Value(s)
28th Nov 20246:09 pmRNSAnnual Financial Report
28th Nov 202410:30 amRNSNet Asset Value(s)
28th Nov 20247:02 amRNSDirectorate Change
28th Nov 20247:01 amRNSDividend Declaration
28th Nov 20247:00 amRNSFinal Results
27th Nov 202410:25 amRNSNet Asset Value(s)
26th Nov 202410:29 amRNSNet Asset Value(s)
25th Nov 202411:24 amRNSNet Asset Value(s)
22nd Nov 202410:18 amRNSNet Asset Value(s)
21st Nov 202411:01 amRNSNet Asset Value(s)
20th Nov 202410:51 amRNSNet Asset Value(s)
19th Nov 202411:02 amRNSNet Asset Value(s)
18th Nov 20245:11 pmRNSHolding(s) in Company
18th Nov 202411:18 amRNSNet Asset Value(s)
15th Nov 202411:12 amRNSNet Asset Value(s)
14th Nov 202410:28 amRNSNet Asset Value(s)
13th Nov 20245:22 pmRNSHolding(s) in Company
13th Nov 202410:52 amRNSNet Asset Value(s)
12th Nov 202410:39 amRNSNet Asset Value(s)
11th Nov 202411:26 amRNSNet Asset Value(s)
8th Nov 202410:36 amRNSNet Asset Value(s)
7th Nov 202410:35 amRNSNet Asset Value(s)
6th Nov 202410:40 amRNSNet Asset Value(s)
5th Nov 202410:40 amRNSNet Asset Value(s)
4th Nov 202411:12 amRNSNet Asset Value(s)
1st Nov 20245:29 pmRNSPortfolio Update
1st Nov 202410:34 amRNSNet Asset Value(s)
31st Oct 20245:08 pmRNSDirector Declaration
31st Oct 202410:31 amRNSNet Asset Value(s)
30th Oct 202410:25 amRNSNet Asset Value(s)
29th Oct 20242:24 pmRNSCompliance with Market Abuse Regulations
29th Oct 202410:26 amRNSNet Asset Value(s)
28th Oct 202411:30 amRNSNet Asset Value(s)
25th Oct 202410:50 amRNSNet Asset Value(s)
24th Oct 202411:25 amRNSNet Asset Value(s)
23rd Oct 202410:28 amRNSNet Asset Value(s)
22nd Oct 202410:17 amRNSNet Asset Value(s)
21st Oct 202410:52 amRNSNet Asset Value(s)
18th Oct 202411:16 amRNSNet Asset Value(s)
17th Oct 202410:58 amRNSNet Asset Value(s)
16th Oct 202411:22 amRNSNet Asset Value(s)
15th Oct 202411:46 amRNSNet Asset Value(s)
14th Oct 202411:15 amRNSNet Asset Value(s)
11th Oct 202410:52 amRNSNet Asset Value(s)
10th Oct 202411:01 amRNSNet Asset Value(s)
9th Oct 202410:40 amRNSNet Asset Value(s)
8th Oct 202410:49 amRNSNet Asset Value(s)
7th Oct 202411:08 amRNSNet Asset Value(s)
4th Oct 202410:47 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.